Lower respiratory tract infections (LTRIs): An insight into the prevalence and the antibiogram of the gram negative, respiratory, bacterial agents

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 2, 2013, Pages 253-256

  Ahmed, Syed Mustaq ^a   Jakribettu, Ramakrishna Pai ^a   Meletath, Shaniya Koyakutty ^a   Arya, B ^a   Shakir, V P A ^a  

^a MES Medical College   (India)

Author keywords

Gram negative bacilli; Multidrug resistance

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ACINETOBACTER BAUMANNII; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CITROBACTER FREUNDII; CITROBACTER KOSERI; DISEASE SURVEILLANCE; DISK DIFFUSION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INDIA; INFANT; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SEX RATIO; SPUTUM ANALYSIS; UNIVERSITY HOSPITAL;

EID: 84873933320     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5308.2740     Document Type: Article

References (12)

1. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001; 56(2):109-14.
2. Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patients. Lung India. 2010 Apr;27(2):54-57.
3. Olugbue V, Onuoha S. Prevalence and antibiotic sensitivity of bacterial agents involved in lower respiratory tract infections. International Journal of Biological and Chemical Sciences. 2011; 5(2): pages?
4. Goel N, Chaudhary U, Aggarwal R, and Bala K. Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the intensive care unit. Indian J Crit Care Med. 2009 Jul-Sep; 13(3): 148-51.
5. Gagneja D, Goel N, Aggarwal R, and Chaudhary U. Changing trend of antimicrobial resistance among gramnegative bacilli isolated from lower respiratory tract of ICU patients: A 5-year study. Indian J Crit Care Med. 2011 Jul-Sep; 15(3): 164-67.
6. Akingbade O, Ogiogwa J, Okerentugba P, Innocent-Adiele H, Onoh C, Nwanze J, et al. Prevalence and Antibiotic Susceptibility Pattern of Bacterial Agents Involved In Lower Respiratory Tract Infections in Abeokuta, Ogun State, Nigeria. Report and opinion. 2012;4(5):25-30.
7. Kumari HBV, Nagarathna S, Chandramuki A. Antimicrobial resistance pattern among aerobic gramnegative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre. Indian journal of chest diseases and allied sciences. 2007; 49(1):19.
8. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. 5th ed. Philadelphia: Lippincott; 1997. Colour Atlast and Test book of Diagnostic Microbiology.
9. Cockerill FR, Wikler MA, Bush K, Dudley MN, Eliopoulos GM, Hardy DJ, et al. Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard. CLSI. 2009; 29(1):11-12.
10. Kaul S, Brahmadathan K, Jagannati M, Sudarsanam T, Pitchamuthu K, Abraham O, et al. One year trends in the gramnegative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India. Indian Journal of Medical Microbiology. 2007; 25(3):230.
11. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention. American journal of respiratory and critical care medicine. 2001; 163(7):1730-54.
12. Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Journal of Antimicrobial Chemotherapy. 1999; 43(3):389-97.